Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Wijermans

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
FEBS Letters|September 28, 1987
Changes in the expression of N-acetylglucosaminyltransferase III, IV, V associated with the differentiation of HL-60 cellsA H Koenderman, P W Wijermans, D H van den Eijnden
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosisD Evers, J L Kerkhoffs, L Van Egmond, et al.
Mycoses|March 1, 1996
Systemic Fusarium nygamai infection in a patient with lymphoblastic non-Hodgkin's lymphomaJ W Krulder, R W Brimicombe, P W Wijermans, et al.
Leukemia Research|June 19, 2004
The effects of 5-aza-2'-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromesJoan van den Bosch, Michael Lübbert, Gregor Verhoef, et al.
Annals of Hematology|October 8, 2005
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patientsP W Wijermans, M Lübbert, G Verhoef, et al.
Ophthalmic Paediatrics and Genetics|September 1, 1990
The Hermansky-Pudlak syndrome. Variable reaction to 1-desamino-8D-arginine vasopressin for correction of the bleeding timeD B Van Dorp, P W Wijermans, F Meire, et al.
The Netherlands Journal of Medicine|June 1, 1990
Cryptococcal meningo-encephalitis after prolonged corticosteroid therapyJ G Koeleman, C Rustemeijer, P W Wijermans, et al.
Leukemia|January 1, 1997
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndromeP W Wijermans, J W Krulder, P C Huijgens, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Multiple myeloma; treatment in the year 1998]H M Lokhorst, P Sonneveld, P W Wijermans, et al.
Leukemia|March 1, 1997
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndromeP W Wijermans, J W Krulder, P C Huijgens, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
FEBS Letters|September 28, 1987
Changes in the expression of N-acetylglucosaminyltransferase III, IV, V associated with the differentiation of HL-60 cellsA H Koenderman, P W Wijermans, D H van den Eijnden
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosisD Evers, J L Kerkhoffs, L Van Egmond, et al.
Mycoses|March 1, 1996
Systemic Fusarium nygamai infection in a patient with lymphoblastic non-Hodgkin's lymphomaJ W Krulder, R W Brimicombe, P W Wijermans, et al.
Leukemia Research|June 19, 2004
The effects of 5-aza-2'-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromesJoan van den Bosch, Michael Lübbert, Gregor Verhoef, et al.
Annals of Hematology|October 8, 2005
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patientsP W Wijermans, M Lübbert, G Verhoef, et al.
Ophthalmic Paediatrics and Genetics|September 1, 1990
The Hermansky-Pudlak syndrome. Variable reaction to 1-desamino-8D-arginine vasopressin for correction of the bleeding timeD B Van Dorp, P W Wijermans, F Meire, et al.
The Netherlands Journal of Medicine|June 1, 1990
Cryptococcal meningo-encephalitis after prolonged corticosteroid therapyJ G Koeleman, C Rustemeijer, P W Wijermans, et al.
Leukemia|January 1, 1997
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndromeP W Wijermans, J W Krulder, P C Huijgens, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Multiple myeloma; treatment in the year 1998]H M Lokhorst, P Sonneveld, P W Wijermans, et al.
Leukemia|March 1, 1997
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndromeP W Wijermans, J W Krulder, P C Huijgens, et al.
Pageof 9